Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1990 Jan;34(1):40-3.
doi: 10.1128/AAC.34.1.40.

Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis

Affiliations
Clinical Trial

Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis

L O Gentry et al. Antimicrob Agents Chemother. 1990 Jan.

Abstract

We undertook a prospective, randomized comparison of oral ciprofloxacin with standard parenteral therapies for the treatment of biopsy-proven osteomyelitis caused by susceptible organisms. Following surgical debridement, the ciprofloxacin patients received 750 mg twice a day, and the other patients received a broad-spectrum cephalosporin or a nafcillin-aminoglycoside combination intravenously (i.v.). There were 31 evaluable patients in the ciprofloxacin group, treated an average of 56 days, and 28 in the i.v. group, treated an average of 47 days. Clinical success rates were 24 of 31 (77%) for the ciprofloxacin group and 22 of 28 (79%) for the i.v. group. Of the seven failures in the ciprofloxacin group, one was due to a persistent Klebsiella pneumoniae infection and six were due to relapse of the infection within 1 year of therapy. Of the six failures in the i.v. group, one was due to an Enterobacter aerogenes strain which emerged resistant and five were due to relapse. The most troublesome etiology was polymicrobial osteomyelitis involving Pseudomonas aeruginosa, in which five of six (83%) regimens failed. Adverse reactions occurred infrequently, i.e., in 1 of 31 (3%) of the ciprofloxacin patients and in 4 of 28 (14%) of the i.v. patients, yet all reactions responded to therapy and none required protocol deviation. Our data indicate that oral ciprofloxacin monotherapy is as safe and effective as conventional parenteral therapy in cases of osteomyelitis caused by susceptible organisms.

PubMed Disclaimer

References

    1. N Engl J Med. 1980 Aug 14;303(7):360-70 - PubMed
    1. Antimicrob Agents Chemother. 1983 Nov;24(5):784-6 - PubMed
    1. J Antimicrob Chemother. 1988 Apr;21 Suppl C:115-31 - PubMed
    1. J Antimicrob Chemother. 1986 Nov;18 Suppl D:21-9 - PubMed
    1. Antimicrob Agents Chemother. 1984 Mar;25(3):319-26 - PubMed